[ Price : $8.95]
The manufacturer of the abortion pill mifepristone sues West Virginia over the states law that effectively bans using the drug for...[ Price : $8.95]
Merck terminates a Phase 3 trial of its Keytruda with other drugs as a treatment for some prostate cancers after an interim data r...[ Price : $8.95]
An FDA advisory committee votes 14 to 1 to recommend that a Cidara Therapeutics NDA for rezafungin demonstrated a favorable benefi...[ Price : $8.95]
Emails released by FDA provide a glimpse of a frustrated senior FDA vaccine official arguing why her office could not compress its...[ Price : $8.95]
The American Pharmacists Association urges pharmacies to join them in calling for FDA to postpone the upcoming Drug Supply Chain S...[ Price : $8.95]
Former FDA Oncologic Drugs Advisory Committee chairman Mikkael Sekeres looks at seven ways in which sponsor committee presentation...[ Price : $8.95]
FDA announces a 3/22 Peripheral and Central Nervous System Drugs Advisory Committee to review Biogens tofersen, an investigational...[ Price : $8.95]
Verrica Pharmaceuticals resubmits an NDA resubmission for VP-102 to treat molluscum contagiosum, described by the Centers for Dise...